Great news from #eleva, the company I founded 26 years ago:
Eleva advances CPV-104 into Phase 1b clinical testing in patients with C3G, following the successful completion of single ascending dose evaluation in healthy volunteers
#biopharmaceutical #mossmade
elevabiologics.com/eleva-is-adv...
3
2
0
0